Radiology Key

PET and SPECT-CT in Lymphoma Karoline Spaepen Sigrid Stroobants Positron emission tomography (PET) using fluorodeoxyglucose (FDG) is now widely used for staging and monitoring treatment results in patients with Hodgkin…

PET-CT and SPECT-CT of Malignant Melanoma Hans C. Steinert In our institution, whole-body integrated positron emission tomography (PET) and computed tomography (CT) with fluorodeoxyglucose (FDG) is restricted to patients with…

PET and PET-CT in Soft Tissue Sarcomas Janet F. Eary Soft tissue sarcomas are a complex group of neoplasms that are derived from mesenchymal tissue elements. They most commonly occur…

PET-CT and SPECT-CT of Bone Metastases Klaus Strobel Daniela B. Husarik Thomas F. Hany The skeletal system is the third most common localization of distant metastases of malignant tumors, following…

PET-CT and SPECT-CT of Malignant Bone Tumors Janet F. Eary Bone sarcomas present a number of diagnostic and treatment challenges. These tumors occur most frequently in older children and young…

PET and PET-CT of Tumors of the Female Genital Tract Lilie L. Lin Farrokh Dehdashti Barry A. Siegel Perry W. Grigsby Gynecologic malignancies as a group represent a major worldwide…

PET-CT and SPECT-CT in Prostate Cancer Daniela B. Husarik Thomas F. Hany Positron emission tomography (PET) using [11C]- and [18F]-labeled choline analogs has shown promising initial results for prostate cancer…

SPECT-CT Imaging of Sentinel Lymph Nodes in Breast Cancer Daniela B. Husarik Hans C. Steinert One of the promising clinical uses of integrated single-photon emission computed tomography (SPECT) and computed…

PET and PET-CT of Testicular Cancer Thomas F. Hany Klaus Strobel Testicular cancer consists of two general groups: seminomatous and nonseminomatous testicular cancers. Very much as in staging of other…

PET and PET-CT in Kidney Tumors and Bladder Cancer Hossein Jadvar Peter S. Conti The role of positron emission tomography (PET) and integrated PET and computed tomography (CT) in the…